Point72 Middle East Fze Gilead Sciences, Inc. Call Options Transaction History

Point72 Middle East Fze

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $3.67 Million - $4.16 Million	-50,100 Reduced 76.02%	15,800 $1.28 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $2.87 Million - $3.13 Million	38,800 Added 143.17%	65,900 $4.94 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $1.42 Million - $1.62 Million	18,700 Added 222.62%	27,100 $2.09 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $286,047 - $325,896	-3,700 Reduced 30.58%	8,400 $696,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $754,072 - $1.08 Million	12,100 New	12,100 $0

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.